Earnings Alerts

China Overseas Land & Investment (688) Earnings: July Contract Sales Surge 10.4%

  • Significant Growth in July: China Overseas Land reported a 10.4% increase in contract sales for July 2024.
  • Sales Achievements: The company achieved contracted sales worth 13.19 billion yuan in July alone.
  • Year-to-Date Performance: The total contracted sales for the year-to-date (YTD) reached 161.57 billion yuan.
  • Analyst Ratings: The company received positive analyst recommendations with:
    • 32 buys
    • 1 hold
    • 0 sells

A look at China Overseas Land & Investment Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Overseas Land & Investment Limited, a company specializing in real estate services, is positioned for a positive long-term outlook based on the Smartkarma Smart Scores. With strong scores of 4 in both Value and Dividend categories, the company demonstrates solid fundamentals and a commitment to providing returns to its investors. While scoring slightly lower in Growth, Resilience, and Momentum categories with scores of 3, the company still maintains a competitive position in the market.

Overall, China Overseas Land & Investment‘s Smart Scores indicate a favorable outlook, particularly in terms of value and dividend returns. As a global provider of real estate services, the company’s focus on developing and managing commercial properties sets a strong foundation for continued growth and resilience in the industry. With a balanced approach towards value, dividends, growth, resilience, and momentum, China Overseas Land & Investment is poised to deliver sustainable performance for its stakeholders in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars